BIO-Key International Inc (BKYI) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company is facing declining financial performance, lacks significant positive trading trends, and has no strong proprietary trading signals. While there is a recent strategic agreement that could be a long-term positive catalyst, the current technical indicators and financials do not support an immediate buy decision.

Technical Analysis

The MACD histogram is slightly positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 65.47, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 0.625), which could limit further upside in the short term.

Positive Catalysts

BIO-Key has signed a multi-year strategic agreement with Mozambique's SIMO to enhance identity and access security in the national electronic payments network. This could provide long-term growth opportunities.

Neutral/Negative Catalysts

The company's financial performance in Q3 2025 shows a significant revenue decline of -27.75% YoY and a sharp drop in EPS (-61.54% YoY). Gross margin also declined by -1.80% YoY, indicating operational challenges.

Financial Performance

In Q3 2025, revenue dropped significantly to $1,549,706 (-27.75% YoY). Net income improved slightly to -$964,849 (+30.57% YoY), but EPS fell sharply to -0.15 (-61.54% YoY). Gross margin also declined to 76.9% (-1.80% YoY). Overall, the financials indicate declining growth and profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data is available for BKYI.

Analyst Rating

Wall Street analysts forecast BKYI stock price to rise

Buy

Hold

Sell

Current: 0.654

Low

Averages

High